Clarion News

In Vivo Article: A Tale Of Two Pipelines


Dennis Chang, a Clarion principal, recently partnered with Dr. Keith Flaherty of MGH and Uciane Scarlett of Oxford Sciences Innovation to publish the following In Vivo article – A Tale Of Two Pipelines: The Promise And Pitfalls Of IO Exuberance And How To Rethink The Approach To Cancer Innovation.

The article was generated from discussions during last year’s Emerging Frontiers in Oncology Summit, which raised funds for Luke Timmerman’s Kilimanjaro Climb to Fight Cancer team for the Fred Hutchinson Cancer Research Center.

This thought piece acknowledges the exciting achievements of the immuno-oncology (I-O) field, while highlighting the inefficiencies of the current profusion of me-too I-O products and studies. Moreover, the piece outlines 3 ways in which we can pursue cancer innovation in a smarter manner: by rethinking our translational models, rethinking data ownership, and rethinking the paradigm for clinical development and clinical practice.

Read the full article authored by Clarion principal Dennis Chang, Dr. Keith Flaherty, and Uciane Scarlett

Is Clarion the right place to advance your career?

Find out more about joining Clarion’s team of innovation advisors.

A life sciences strategy and organizational consultancy that collaborates with its clients to envision, craft and enable growth through innovation and leadership.